Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Kenneth Vaz

Orthopaedic Surgery Washington, DC Medical Doctor

NPI 1194064824 CMS profile 1395177

3800 Reservoir Rd Nw, Washington, DC 20007

Open in the dashboard

General payments

$7,823

80 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kenneth Vaz of Washington, DC is reported in the CMS Open Payments database as having received $7,823 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,972 21
2024 General $935 9
2023 General $1,151 14
2022 General $1,313 19
2021 General $1,300 15
2020 General $151 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Vaz
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kenneth Vaz were reported at $2,972. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kenneth Vaz Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $151 $312 $75–$1,860 $114
2021 $1,300 $520 $117–$2,495 $132
2022 $1,313 $598 $128–$2,731 $149
2023 $1,151 $461 $128–$2,264 $160
2024 $935 $497 $134–$2,475 $164
2025 $2,972 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Zimmer Biomet Holdings, Inc. $3,423 33 payments
  2. Stryker Corporation $1,925 29 payments
  3. DePuy Synthes Sales Inc. $1,445 6 payments
  4. Avanos Medical $265 2 payments
  5. Biocomposites Inc $211 2 payments
  6. Shalby Advanced Technologies, Inc. $203 1 payment
  7. Davol Inc. $194 1 payment
  8. Bone Support Inc. $70 1 payment
  9. Medical Device Business Services, Inc. $53 3 payments
  10. Ethicon US, LLC $19 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $4,476 61 payments
  2. Travel and Lodging $2,019 15 payments
  3. Consulting Fee $830 1 payment
  4. Education $498 3 payments
Products named General payments · program years 2020–2025
  1. Oxford $1,346 12 payments
  2. Persona Knees $676 6 payments
  3. MAKO $527 14 payments
  4. Persona Knees $500 3 payments
  5. ROSA-Knee $454 6 payments
  6. ATTUNE $344 3 payments
  7. Oxford-Knees $316 1 payment
  8. Velys $286 4 payments
  9. COOLIEF* COOLED RADIOFREQUENCY $265 2 payments
  10. ACTIS $240 2 payments
  11. Other $3,178 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

264

Median for Orthopedic Surgery: 203

Drug cost

$1,913

Median for Orthopedic Surgery: $1,433

Branded share of claims

4.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 28 $555
Oxycodone Hcl Generic 51 $268
Diclofenac Sodium Generic 12 $250
Meloxicam Generic 100 $243
Ibuprofen Generic 14 $185
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 12 $174
Gabapentin Generic 13 $131
Tramadol Hcl Generic 22 $85
Amoxicillin Generic 12 $21

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$307,822

Of which drugs: $7,286

Medicare patients

664

Average age 74

Services billed

1,424

455 women, 209 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 27%
Ischemic heart disease 24%
Osteoporosis 20%
Chronic kidney disease 19%
Cancer 18%
Depression 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record